Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
24 January 2019 | Story Lacea Loader | Photo Sonia Small
Dr Engela van Staden
Dr Engela van Staden started as Vice-Rector: Academic on 1 January 2019.
The Executive Committee of the Council (on behalf of Council) of the University of the Free State (UFS) approved the appointment of Dr Engela van Staden as Vice-Rector: Academic during a meeting held on 5 December 2018. She started on 1 January 2019 as Vice-Rector: Academic (designate) and will take up the position from 1 February 2019 as Vice-Rector:  Academic. Prof Hendri Kroukamp, who acted in the position of Vice-Rector: Academic, will resume his portfolio as Dean: Faculty of Economic and Management Sciences on 1 February 2019. 

“Dr Van Staden has an immense knowledge of the higher-education system, governance, planning, and policy frameworks within the sector, and of enrolment planning and management, and will provide leadership within this domain. She has been in senior management positions at faculty, institutional, and national level for a period of 20 years and is one of the experts in academic-programme development and curriculum design in the country. I look forward to working with her and welcoming her to the university,” says Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.
 
Dr Van Staden holds a DPhil in Education from the Rand Afrikaans University (now University of Johannesburg). She was Deputy Vice-Chancellor: Teaching, Learning and Community Engagement at the Sefako Makgatho Health Sciences University. Prior to this she was, among others, Chief Director: University Academic Planning and Management Support at the Department of Higher Education and Training (DHET) from 2009 to 2017, Director: Strategic Management Support at Tshwane University of Technology from 2004 to 2009, Dean: Faculty of Education and Director: Strategic Planning at the then Technikon Northern Gauteng from 1996 to 2003. 
 
Her responsibilities at the Sefako Makgatho Health Sciences University included teaching and learning, quality assurance, strategic and academic planning, technology and education innovation, planning and reporting for and on earmarked and development grants, curriculum reviews, infrastructure planning, blended learning, and the redesign of the university’s business model.
 
In the portfolio of Chief Director: University Academic Planning and Management Support at the DHET, she was responsible for, among others, the national enrolment targets of 2013 and 2019, and institutional performance targets aligned to the Minister’s performance targets, the management and approval of all national programme applications, the development of the distance policy for universities / open learning strategy, the monitoring of universities under administration, the Medium Term Expenditure Framework (MTEF) budget allocations to universities, the planning and establishing of new universities in Mpumalanga and Northern Cape with specific reference to the academic programmes and governance and policy environment, and the establishment of the Central Application System (CAS) and Service and Clearing House Mechanism (CACH), which includes a project management office, business architecture and the formulation of proposals towards the governance and management of such a function.
 
She has supervised master’s and doctoral students, authored and co-authored a number of academic articles, compiled a vast array of technical reports, and participated in a wide variety of national and international projects in South Africa and abroad.

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 
When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?
Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept